These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 15930285)

  • 1. Interleukin 6 supports the maintenance of p53 tumor suppressor gene promoter methylation.
    Hodge DR; Peng B; Cherry JC; Hurt EM; Fox SD; Kelley JA; Munroe DJ; Farrar WL
    Cancer Res; 2005 Jun; 65(11):4673-82. PubMed ID: 15930285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic silencing of the human nucleotide excision repair gene, hHR23B, in interleukin-6-responsive multiple myeloma KAS-6/1 cells.
    Peng B; Hodge DR; Thomas SB; Cherry JM; Munroe DJ; Pompeia C; Xiao W; Farrar WL
    J Biol Chem; 2005 Feb; 280(6):4182-7. PubMed ID: 15550378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The DNA methyltransferase inhibitors zebularine and decitabine induce mitochondria-mediated apoptosis and DNA damage in p53 mutant leukemic T cells.
    Ruiz-Magaña MJ; Rodríguez-Vargas JM; Morales JC; Saldivia MA; Schulze-Osthoff K; Ruiz-Ruiz C
    Int J Cancer; 2012 Mar; 130(5):1195-207. PubMed ID: 21455989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of DNA methyltransferase-mediated gene silencing, anchorage-independent growth, and migration of colon cancer cells by interleukin-6.
    Foran E; Garrity-Park MM; Mureau C; Newell J; Smyrk TC; Limburg PJ; Egan LJ
    Mol Cancer Res; 2010 Apr; 8(4):471-81. PubMed ID: 20354000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of p53 epigenetic silencing in multiple myeloma permits apoptosis by a p53 activator.
    Hurt EM; Thomas SB; Peng B; Farrar WL
    Cancer Biol Ther; 2006 Sep; 5(9):1154-60. PubMed ID: 16855375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-6 expression was regulated by epigenetic mechanisms in response to influenza virus infection or dsRNA treatment.
    Tang B; Zhao R; Sun Y; Zhu Y; Zhong J; Zhao G; Zhu N
    Mol Immunol; 2011 Apr; 48(8):1001-8. PubMed ID: 21353307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 expression after treatment with zebularine is not due to demethylation.
    Brandes JC; Herman JG
    Cancer Res; 2006 Jul; 66(13):6892; author reply 6893. PubMed ID: 16818668
    [No Abstract]   [Full Text] [Related]  

  • 9. DNA methyltransferase inhibitor zebularine induces human cholangiocarcinoma cell death through alteration of DNA methylation status.
    Nakamura K; Nakabayashi K; Htet Aung K; Aizawa K; Hori N; Yamauchi J; Hata K; Tanoue A
    PLoS One; 2015; 10(3):e0120545. PubMed ID: 25799509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell division is required for de novo methylation of CpG islands in bladder cancer cells.
    Velicescu M; Weisenberger DJ; Gonzales FA; Tsai YC; Nguyen CT; Jones PA
    Cancer Res; 2002 Apr; 62(8):2378-84. PubMed ID: 11956100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-6 contributes to growth in cholangiocarcinoma cells by aberrant promoter methylation and gene expression.
    Wehbe H; Henson R; Meng F; Mize-Berge J; Patel T
    Cancer Res; 2006 Nov; 66(21):10517-24. PubMed ID: 17079474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zebularine inhibits human acute myeloid leukemia cell growth in vitro in association with p15INK4B demethylation and reexpression.
    Scott SA; Lakshimikuttysamma A; Sheridan DP; Sanche SE; Geyer CR; DeCoteau JF
    Exp Hematol; 2007 Feb; 35(2):263-73. PubMed ID: 17258075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylation-associated dysregulation of the suppressor of cytokine signaling-3 gene in multiple myeloma.
    Wilop S; van Gemmeren TB; Lentjes MH; van Engeland M; Herman JG; Brümmendorf TH; Jost E; Galm O
    Epigenetics; 2011 Aug; 6(8):1047-52. PubMed ID: 21934357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Xeroderma pigmentosum group C gene expression is predominantly regulated by promoter hypermethylation and contributes to p53 mutation in lung cancers.
    Wu YH; Tsai Chang JH; Cheng YW; Wu TC; Chen CY; Lee H
    Oncogene; 2007 Jul; 26(33):4761-73. PubMed ID: 17325666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimitogenic and chemosensitizing effects of the methylation inhibitor zebularine in ovarian cancer.
    Balch C; Yan P; Craft T; Young S; Skalnik DG; Huang TH; Nephew KP
    Mol Cancer Ther; 2005 Oct; 4(10):1505-14. PubMed ID: 16227399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactivation of the 14-3-3 sigma gene is associated with 5' CpG island hypermethylation in human cancers.
    Suzuki H; Itoh F; Toyota M; Kikuchi T; Kakiuchi H; Imai K
    Cancer Res; 2000 Aug; 60(16):4353-7. PubMed ID: 10969776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The candidate tumor suppressor gene BLU, located at the commonly deleted region 3p21.3, is an E2F-regulated, stress-responsive gene and inactivated by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma.
    Qiu GH; Tan LK; Loh KS; Lim CY; Srivastava G; Tsai ST; Tsao SW; Tao Q
    Oncogene; 2004 Jun; 23(27):4793-806. PubMed ID: 15122337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of p53 represses E-cadherin expression by increasing DNA methyltransferase-1 and promoter methylation in serous borderline ovarian tumor cells.
    Cheng JC; Auersperg N; Leung PC
    Oncogene; 2011 Sep; 30(37):3930-42. PubMed ID: 21478913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGF-β induces global changes in DNA methylation during the epithelial-to-mesenchymal transition in ovarian cancer cells.
    Cardenas H; Vieth E; Lee J; Segar M; Liu Y; Nephew KP; Matei D
    Epigenetics; 2014 Nov; 9(11):1461-72. PubMed ID: 25470663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic silencing of the interferon regulatory factor ICSBP/IRF8 in human multiple myeloma.
    Tshuikina M; Jernberg-Wiklund H; Nilsson K; Oberg F
    Exp Hematol; 2008 Dec; 36(12):1673-1681. PubMed ID: 18922617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.